ACV Auctions, Inc. Class A ACVA 深 滬
已收盤 02-06 16:00:00 美东时间
7.37
+0.320
+4.54%
華盛通- 最 高7.425
- 今 開7.13
- 成交量 263.90万股
- 最 低 7.01
- 昨 收 7.05
- 總市值 12.69亿
- 52周最高 21.50
- 市盈率 靜 --
- 換手率 1.53%
- 52周最低 4.95
- 委 比 -18.34%
- 總股本 1.72亿
- 歷史最高 37.77
- 量 比 0.73
- 振 幅 5.89%
- 歷史最低 4.95
- 每 手 1
- 風險率 3.86%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ACV Auctions Unveils AI-Powered VIPER Inspection Towers at 2026 NADA Conference
ACV Auctions Unveils AI-Powered VIPER Inspection Towers at 2026 NADA Conference ACV Auctions Inc. attended the 2026 National Automobile Dealers Association (NADA) Conference, where the company demonstrated its VIPER AI-powered inspection towers. At the event, ACV announced the expansion of its VIPER
02-03 01:08
ACV Auctions Inc. to Report Fourth Quarter 2025 Financial Results
ACV Auctions Inc. to Report Fourth Quarter 2025 Financial Results ACV Auctions Inc. will report its fourth quarter 2025 financial results after market close on February 23, 2026. A conference call for investors and analysts will be held at 5:00 p.m. ET the same day. The results and a live webcast of
01-27 05:05
美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元
01-22 15:09
Barclays Maintains Equal-Weight on ACV Auctions, Raises Price Target to $8
Barclays analyst John Babcock maintains ACV Auctions (NYSE:ACVA) with a Equal-Weight and raises the price target from $7 to $8.
01-21 22:21
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
2025-12-05 08:35
Barclays Maintains Equal-Weight on ACV Auctions, Raises Price Target to $7
Barclays analyst John Babcock maintains ACV Auctions (NYSE:ACVA) with a Equal-Weight and raises the price target from $6 to $7.
2025-12-04 23:41
美股大行评级 | 最高130美元！11家大行集体上调沃尔玛目标价；戴康工业、Gap、罗斯百货等均或多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Fractyl Health"买入"评级，目标价从6美元升至8美元；HC Wainwright & Co.：维持MediWound"买入"评级，目标价从31美元升至36美元
2025-11-24 11:23
Citigroup Maintains Buy on ACV Auctions, Lowers Price Target to $13
Citigroup analyst Ronald Josey maintains ACV Auctions (NYSE:ACVA) with a Buy and lowers the price target from $17 to $13.
2025-11-22 04:11
美股牛股 | 美国火箭制造商Firefly涨17%，Q3业绩超预期且中标多项合同；希悦尔涨近17%
美国火箭制造商FLY涨17%，Q3业绩超预期且中标多项合同；希悦尔涨近17%，与私募公司就私有化进行谈判>>
2025-11-14 18:48
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
2025-11-13 09:58
